Sutro Biopharma, Inc. (STRO) has 20 已知的内部人和机构持有人记录. 最大持有人为 MOLINA ARTURO MD 持有 37,500 股. 其他重要持有人包括 Freund John Gordon 和 NEWELL WILLIAM J.
过去12个月，内部人进行了 44 笔交易，涉及 STRO 股票 — 28 笔买入 (价值为 $796.23K) 和 0 笔卖出 (价值为 RSU 奖励). 内部人买入超过卖出，可能表明对公司前景有信心.
STRO 內部人持股
最大持股人
MOLINA ARTURO MD
37,500 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Molina Arturo Md |
Chief Medical Officer |
37,500 |
2022-03-07 |
|
| 2 |
Freund John Gordon |
Director |
35,000 |
2024-06-10 |
|
| 3 |
Newell William J |
CEO |
31,125 |
2025-03-06 |
|
| 4 |
Worsley Stephen |
Chief Business Officer |
30,000 |
2019-01-31 |
|
| 5 |
Lawlis V Bryan |
Director |
26,033 |
2018-09-27 |
|
| 6 |
Sharp Shalini |
Director |
18,500 |
2022-06-08 |
|
| 7 |
Borgman Anne Elizabeth |
Chief Medical Officer |
17,812 |
2025-05-05 |
|
| 8 |
Shabbir Anik |
Chief Technical Ops. Officer |
17,500 |
2023-03-07 |
|
| 9 |
Leyman Barbara |
Chief Business Officer |
16,056 |
2025-08-26 |
|
| 10 |
Albini Edward C |
CFO and Secretary |
15,750 |
2025-03-04 |
|
| 11 |
Shtylla Brunilda |
Chief Business Officer |
12,928 |
2023-08-28 |
|
| 12 |
Janney Daniel |
Director |
11,610 |
2019-06-19 |
|
| 13 |
Fitzpatrick Linda A |
Chief People & Comm. Officer |
9,125 |
2025-03-06 |
|
| 14 |
Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
7,500 |
2023-04-17 |
|
| 15 |
Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
6,500 |
2023-07-13 |
|
| 16 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
5,000 |
2025-05-05 |
|
| 17 |
Chow Gregory K. |
CFO |
5,000 |
2026-03-03 |
|
| 18 |
Ross Michael Jay |
10 Percent Owner |
4,315 |
2018-10-01 |
|
| 19 |
Svlsf V, Llc |
10 Percent Owner |
4,315 |
2018-10-01 |
|
| 20 |
Gerber Hans-peter |
Chief Scientific Officer |
2,250 |
2026-03-03 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-03-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
期权行权（卖出） |
675 |
- |
- |
| 2026-03-04 |
Chung Jane |
Chief Executive Officer |
期权行权（卖出） |
788 |
- |
- |
| 2026-03-02 |
Pauling David |
Chief Admin. Ofcr. & Gc |
限制性股票授予 (RSU) |
4,200 |
- |
- |
| 2026-03-01 |
Pauling David |
Chief Admin. Ofcr. & Gc |
期权行权（卖出） |
500 |
- |
- |
| 2026-03-02 |
Gerber Hans-peter |
Chief Scientific Officer |
限制性股票授予 (RSU) |
5,000 |
- |
- |
| 2026-03-01 |
Gerber Hans-peter |
Chief Scientific Officer |
期权行权（卖出） |
1,125 |
- |
- |
| 2026-03-02 |
Chung Jane |
Chief Executive Officer |
RSU 预扣税 |
2,779 |
$20.55 |
$57.11K |
| 2026-03-01 |
Chung Jane |
Chief Executive Officer |
期权行权（卖出） |
688 |
- |
- |
| 2026-03-02 |
Chow Gregory K. |
CFO |
限制性股票授予 (RSU) |
5,000 |
- |
- |
| 2025-12-23 |
Pauling David |
Chief Admin. Ofcr. & Gc |
限制性股票授予 (RSU) |
7,200 |
$10.38 |
$74.74K |
| 2025-12-23 |
Gerber Hans-peter |
Chief Scientific Officer |
限制性股票授予 (RSU) |
7,925 |
$10.38 |
$82.26K |
| 2025-12-23 |
Hunter Heidi |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Chow Gregory K. |
CFO |
限制性股票授予 (RSU) |
8,200 |
$10.38 |
$85.12K |
| 2025-12-23 |
Dybbs Michael |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Wigginton Jon Marc |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Jagpal Sukhi |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Lobacki Joseph M |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Petree Daniel H |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Matsui Connie |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Panek James P |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
| 2025-12-12 |
Chung Jane |
Chief Executive Officer |
期权行权（卖出） |
2,500 |
- |
- |
| 2025-10-15 |
Pauling David |
Chief Admin. Ofcr. & Gc |
知情买入 |
12,504 |
$0.80 |
$9.99K |
| 2025-10-15 |
Gerber Hans-peter |
Chief Scientific Officer |
知情买入 |
17,000 |
$0.80 |
$13.61K |
| 2025-10-15 |
Chung Jane |
Chief Executive Officer |
知情买入 |
12,500 |
$0.80 |
$10.01K |
| 2025-10-15 |
Chow Gregory K. |
CFO |
知情买入 |
19,750 |
$0.81 |
$16K |
